Invest in intelligence that delivers

is everything.

Across the pharma lifecycle, an accurate
and complete market view is essential to
stay ahead of the curve and uncover
emerging healthcare trends.

Think beyond the brand.

The more you understand the landscape, the better you can align with market needs and gain a competitive edge.


Broaden your
with Spherix.

We combine robust, independent market data with deep therapeutic expertise and impeccable focus on delivering commercial value.

Harness the power of holistic market intelligence. Make better decisions and unlock opportunities.

We view the market landscape through the lens of your business and deliver customized strategic advisory services.

Spherix delivers:

Market Insights

Gain an unbiased perspective of the market and its potential, independently assess launches, understand the patient journey and prescribers' perspectives, and gauge the impact of disruptive events.

Strategic Sessions

Interactive on-site or virtual  sessions with Spherix therapeutic experts, highlighting commercially relevant analyses, contextual data, and custom insights tailored to your business.

Advisory Services

Fortify your strategy and tactics with our industry experts who are well-equipped to deliver strategic advisory services across the product lifecycle.

Spherix is dedicated to the therapeutic areas we cover.

  • Dermatology Indications Covered:
    • Alopecia Areata
    • Atopic Dermatitis
    • Hidradenitis Suppurativa
    • Plaque Psoriasis
    • Prurigo Nodularis
    • Vitiligo
  • Visit the Spherix portal for the full spectrum of our Dermatology offerings (link to come)
  • Download the Dermatology publication plan (PDF to come)

Gastroenterology Indications Covered:

  • Crohn’s Disease
    Ulcerative Colitis
  • IBS-C
  • Eosinophilic Esophagitis
  • Clostridioides Difficile

Visit the Spherix portal for the full spectrum of our Gastroenterology offering

Download the Gastroenterology publication plan

  • Rheumatology Indications Covered:
    • Rheumatoid Arthritis  
    • Psoriatic Arthritis
    • Ankylosing Spondylitis and Non-Radiographic Axial Spondylitis
    • Systemic Lupus Erythematosus
    • Lupus Nephritis
    • Cutaneous Lupus
    • Polymyalgia Rheumatica
    • Giant Cell Arteritis
    • Dermatomyositis
    • Scleroderma
    • Sjogren’s Syndrome
    • ANCA-associated Vasculitis 
  • Visit the Spherix portal for the full spectrum of our Rheumatology offerings
  • Download the Rheumatology publication plan (PDF to come) 
  • Nephrology Indications Covered: 
    • Hyperkalemia
    • Diabetic Kidney Disease
    • Chronic Kidney Disease (Non-Dialysis)
    • Dialysis
    • Bone and Mineral Metabolism
    • CKD-associated Pruritus
    • Renal Anemia  
    • Polycystic Kidney Disease
    • IgA Nephropathy
    • Focal Segmental Glomerulosclerosis
    • Complement 3 glomerulopathy  
    • Membranous Nephropathy
    • Fabry Disease
    • Alport Syndrome 
  • Visit the Spherix portal for the full spectrum of our Nephrology offerings 
  • Download the Nephrology publication plan (PDF to come) 
  • Neurology Indications Covered: 
    • Alzheimer’s
    • ALS
    • CIDP  
    • Epilepsy
    • Generalized Myasthenia  
    • Gravis  
    • Huntington’s Disease
    • Migraine
    • Multiple Sclerosis
    • Parkinson’s Disease
    • Chronic Stroke  
  • Visit the Spherix portal for the full spectrum of our Neurology  offerings
  • Download the Neurology publication plan (PDF to come) 
  • Ophthalmology Indications Covered:
  • Visit the Spherix portal for the full spectrum of our Ophthalmology  offerings
  • Download the Ophthalmology publication plan (PDF to come) 

Our therapeutic experts are always just a click or call away...

  • Plugged into the ever-evolving landscape
  • Ready to provide an unbiased view of the  landscape
  • Insightfully answer real-time questions
  • Highlight opportunities Identify disruptors

Capitalize on commercially relevant insights and advisory services across the pharma lifecycle.

Independent, holistic intelligence informs tailored support that matches the needs of your business.
Gain an unbiased perspective of the market and its potential.
Reveal the ‘why’ behind treatment decisions and understand the patient journey.
Add context to trending topics and gauge the impact of disruptive events.
Independently assess launches and benchmark history of analogs.
Understand the prescriber’s perspective of the competitive landscape.

Shape what’s next with market intelligence that is trusted and influential.

We work with 17 of the top 20 pharma/biotech organizations, and our expertise is a go-to resource for leading brands, industry media outlets, financial analysts, professional organizations, and patient advocacy groups.


Key Opinion Leaders

Professional Organizations

Media Outlets

Patient Advocacy Groups

Financial Analyst Firms


Pfizer’s Velsipity poised to outpace BMS’ Zeposia in ulcerative colitis market, but must head off further competition: analysts


As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid marketing model


US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the Treatment of…


Gastroenterologists Slow to Adopt Eli Lilly’s Omvoh, Pfizer’s Velsipity, and Takeda’s subcutaneous formulation of Entyvio for…

Talk to an expert

Gianna Melendez
Franchise Head, Dermatology

Jim Hickey
Franchise Head, Gastroenterology

Maxine Yarnall
Franchise Head, Rheumatology

Meghan Weiss
Franchise Head, Nephrology

Blaine Cloud, PhD
Franchise Head, Neurology

Blaine Cloud, PhD
Franchise Head, Ophthalmology

Sign up for alerts, market insights and exclusive content in your inbox.

Spherix is excited to announce our expansion into an additional, rapidly evolving specialty market:


Throughout 2024, we will be publishing over
10 groundbreaking studies covering a wide range of indications within classical hematology.